On May 23, 2023, Anson Funds Management Delivered A Letter To The Chairman Of MEI Pharma Proposing To Acquire All Outstanding Shares Of MEI Not Already Held By Their Respective Funds For Not Less Than $8.00/Share, Plus A CVR
Portfolio Pulse from Charles Gross
Anson Funds Management has proposed to acquire all outstanding shares of MEI Pharma not already held by their respective funds for not less than $8.00/share, plus a CVR.
May 30, 2023 | 9:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Anson Funds Management's proposal to acquire MEI Pharma's outstanding shares for not less than $8.00/share, plus a CVR, may positively impact MEIP's stock price.
The acquisition proposal by Anson Funds Management for MEI Pharma's outstanding shares at a minimum price of $8.00/share, plus a CVR, indicates a potential premium on the current stock price. This news is likely to be perceived positively by investors, leading to an increase in demand for MEIP shares and a potential short-term boost in the stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100